Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis

Arterial ischemia and hemorrhage are associated with bevacizumab, an inhibitor of vascular endothelial growth factor that is widely used to treat many types of cancers. As specific types of arterial ischemia and hemorrhage, cerebrovascular events such as central nervous system (CNS) ischemic events...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Pei-Yuan, Chen, Xing-Lin, Liu, Yu-Wei, Xiao, Chang-Liang, Liu, Cheng-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099178/
https://www.ncbi.nlm.nih.gov/pubmed/25025282
http://dx.doi.org/10.1371/journal.pone.0102484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099178/
https://www.ncbi.nlm.nih.gov/pubmed/25025282
http://dx.doi.org/10.1371/journal.pone.0102484

Ejemplares similares